Unknown

Dataset Information

0

Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers.


ABSTRACT: Homozygous or compound heterozygous (biallelic) variants in PRKN are causal for PD with highly penetrant symptom expression, while the much more common heterozygous variants may predispose to PD with highly reduced penetrance, through altered mitochondrial function. In the presence of pathogenic heterozygous variants, it is therefore important to test for mitochondrial alteration in cells derived from variant carriers to establish potential presymptomatic molecular markers. We generated lymphoblasts (LCLs) and human induced pluripotent stem cell (hiPSC)-derived neurons from non-manifesting heterozygous PRKN variant carriers and tested them for mitochondrial functionality. In LCLs, we detected hyperactive mitochondrial respiration, and, although milder compared to a biallelic PRKN-PD patient, hiPSC-derived neurons of non-manifesting heterozygous variant carriers also displayed several phenotypes of altered mitochondrial function. Overall, we identified molecular phenotypes that might be used to monitor heterozygous PRKN variant carriers during the prodromal phase. Such markers might also be useful to identify individuals at greater risk of eventual disease development and for testing potential mitochondrial function-based neuroprotective therapies before neurodegeneration advances.

SUBMITTER: Castelo Rueda MP 

PROVIDER: S-EPMC10113363 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers.

Castelo Rueda Maria Paulina MP   Zanon Alessandra A   Gilmozzi Valentina V   Lavdas Alexandros A AA   Raftopoulou Athina A   Delcambre Sylvie S   Del Greco M Fabiola F   Klein Christine C   Grünewald Anne A   Pramstaller Peter P PP   Hicks Andrew A AA   Pichler Irene I  

NPJ Parkinson's disease 20230418 1


Homozygous or compound heterozygous (biallelic) variants in PRKN are causal for PD with highly penetrant symptom expression, while the much more common heterozygous variants may predispose to PD with highly reduced penetrance, through altered mitochondrial function. In the presence of pathogenic heterozygous variants, it is therefore important to test for mitochondrial alteration in cells derived from variant carriers to establish potential presymptomatic molecular markers. We generated lymphobl  ...[more]

Similar Datasets

| S-EPMC9626656 | biostudies-literature
| S-EPMC7505004 | biostudies-literature
| S-EPMC6287702 | biostudies-literature
| S-EPMC9832901 | biostudies-literature
| S-EPMC2944769 | biostudies-literature
| S-EPMC10066890 | biostudies-literature
| S-EPMC10187002 | biostudies-literature
| S-EPMC6865680 | biostudies-literature
| S-EPMC9506491 | biostudies-literature
| S-EPMC3681541 | biostudies-literature